Lucid Diagnostics Inc.
LUCD · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Revenue | $4,346 | $2,428 | $377 | $500 |
| % Growth | 79% | 544% | -24.6% | – |
| Cost of Goods Sold | $8,266 | $8,478 | $3,614 | $585 |
| Gross Profit | -$3,920 | -$6,050 | -$3,237 | -$85 |
| % Margin | -90.2% | -249.2% | -858.6% | -17% |
| R&D Expenses | $5,992 | $7,252 | $11,466 | $9,296 |
| G&A Expenses | $20,156,000 | $19,254 | $23,685 | $12,778 |
| SG&A Expenses | $36,619,000 | $35,658 | $39,819 | $18,038 |
| Sales & Mktg Exp. | $16,463,000 | $16,404 | $16,134 | $5,260 |
| Other Operating Expenses | -$36,582,860 | -$478 | $1,649 | $0 |
| Operating Expenses | $42,132 | $42,432 | $52,934 | $27,334 |
| Operating Income | -$46,052 | -$48,482 | -$56,171 | -$27,419 |
| % Margin | -1,059.6% | -1,996.8% | -14,899.5% | -5,483.8% |
| Other Income/Exp. Net | $523 | -$4,184 | $0 | -$659 |
| Pre-Tax Income | -$45,529 | -$52,666 | -$56,171 | -$28,078 |
| Tax Expense | $0 | $0 | $0 | $0 |
| Net Income | -$45,529 | -$52,666 | -$56,171 | -$28,078 |
| % Margin | -1,047.6% | -2,169.1% | -14,899.5% | -5,615.6% |
| EPS | -1.05 | -1.26 | -1.55 | -0.78 |
| % Growth | 16.7% | 18.7% | -98.7% | – |
| EPS Diluted | -1.05 | -1.26 | -1.55 | -0.78 |
| Weighted Avg Shares Out | 50,516 | 41,756 | 36,172 | 36,058 |
| Weighted Avg Shares Out Dil | 50,516 | 41,756 | 36,172 | 36,058 |
| Supplemental Information | – | – | – | – |
| Interest Income | $322 | $424 | $88 | $0 |
| Interest Expense | $26 | $416 | $8 | $659 |
| Depreciation & Amortization | $1,167 | $2,499 | $1,936 | $4 |
| EBITDA | -$44,336 | -$49,751 | -$54,235 | -$27,415 |
| % Margin | -1,020.2% | -2,049.1% | -14,385.9% | -5,483% |